Lung Cancer Trial, Not Yet Recruiting NCT06822348 Sponsor: Centre Hospitalier Henri Duffaut - Avignon Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT06822348
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with stage 4 lung cancer.
  • People whose general physical functioning is rated at WHO level 2 or below (a scale used to measure how much a condition limits daily activity).
  • People whose breathlessness is mild or less, rated at grade 2 or below on a standard breathlessness scale called the mMRC.
  • People who are receiving chemotherapy for the first time (no prior chemotherapy treatment).
  • People whose heart rate variability measurement shows less than 5% interference or signal disturbance during a specific reading called rMSSD (confirm with trial site).
  • People whose SDNN measurement — a reading that reflects overall heart rate variability — is below 70 milliseconds (confirm with trial site).
  • People who have voluntarily agreed to participate and have signed a consent form.
  • People who have no medical reasons preventing them from receiving osteopathic hands-on treatment.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had a surgical procedure cutting the vagus nerve on one or both sides of the body.
  • People who have a heart rhythm disorder (arrhythmia).
  • People who are taking medications that affect heart rhythm, such as anti-arrhythmia drugs or beta-blockers.
  • People whose cancer has returned and who have already received chemotherapy as part of a previous course of treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 1 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Henri Duffaut - Avignon
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Assessment of heart rate variability.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov